P3 Health Partners Stock Performance
| PIII Stock | USD 2.23 0.37 14.23% |
The firm owns a Beta (Systematic Risk) of 0.63, which implies possible diversification benefits within a given portfolio. As returns on the market increase, P3 Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding P3 Health is expected to be smaller as well. At this point, P3 Health Partners has a negative expected return of -2.15%. Please make sure to check P3 Health's standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if P3 Health Partners performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days P3 Health Partners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in March 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (8.07) | Five Day Return (26.79) | Year To Date Return (41.43) | Ten Year Return (99.58) | All Time Return (99.58) |
Last Split Factor 1:50 | Last Split Date 2025-04-14 |
1 | Is P3 Health Partners Inc. stock a good choice for value investors - Trade Risk Assessment Verified Swing Trading Watchlists - newser.com | 11/12/2025 |
2 | Whats Next P3 Health Partnerss Earnings Preview | 11/13/2025 |
3 | What Wall Street predicts for P3 Health Partners Inc. Equity Warrant stock price - Earnings Recap Summary Capital Efficiency Focused Ideas - newser.com | 11/19/2025 |
4 | P3 Health Partners receives Nasdaq notice over minimum equity compliance - Investing.com | 11/28/2025 |
5 | P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO | 12/02/2025 |
6 | P3 Health Partners Neutral Rating Reiterated at BTIG Research | 12/15/2025 |
7 | Will P3 Health Partners Inc. stock see PE expansion - Earnings Overview Report Free Weekly Watchlist of Top Performers - DonanmHaber | 12/19/2025 |
8 | P3 Health Partners Stock Speculative Rebound Play Or Value Trap After A Brutal Year - AD HOC NEWS | 01/06/2026 |
9 | Acquisition by Tolan Mary A of 2000 shares of P3 Health subject to Rule 16b-3 | 01/27/2026 |
| Begin Period Cash Flow | 40.9 M | |
| Total Cashflows From Investing Activities | 14.5 M |
P3 Health Relative Risk vs. Return Landscape
If you would invest 885.00 in P3 Health Partners on November 1, 2025 and sell it today you would lose (662.00) from holding P3 Health Partners or give up 74.8% of portfolio value over 90 days. P3 Health Partners is currently does not generate positive expected returns and assumes 4.906% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than PIII, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
P3 Health Target Price Odds to finish over Current Price
The tendency of PIII Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.23 | 90 days | 2.23 | about 92.93 |
Based on a normal probability distribution, the odds of P3 Health to move above the current price in 90 days from now is about 92.93 (This P3 Health Partners probability density function shows the probability of PIII Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days P3 Health has a beta of 0.63 indicating as returns on the market go up, P3 Health average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding P3 Health Partners will be expected to be much smaller as well. Additionally P3 Health Partners has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. P3 Health Price Density |
| Price |
Predictive Modules for P3 Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as P3 Health Partners. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.P3 Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. P3 Health is not an exception. The market had few large corrections towards the P3 Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold P3 Health Partners, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of P3 Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.99 | |
β | Beta against Dow Jones | 0.63 | |
σ | Overall volatility | 2.06 | |
Ir | Information ratio | -0.42 |
P3 Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of P3 Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for P3 Health Partners can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners currently holds 166.16 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.5 B. Net Loss for the year was (310.38 M) with loss before overhead, payroll, taxes, and interest of (58.45 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (110.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52. | |
| Roughly 62.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Basel Medical Group Ltd Short Interest Update |
P3 Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PIII Stock often depends not only on the future outlook of the current and potential P3 Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. P3 Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.9 M | |
| Cash And Short Term Investments | 38.8 M |
P3 Health Fundamentals Growth
PIII Stock prices reflect investors' perceptions of the future prospects and financial health of P3 Health, and P3 Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PIII Stock performance.
| Return On Equity | -2.03 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 234.58 M | ||||
| Shares Outstanding | 3.27 M | ||||
| Price To Book | 0.62 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 1.5 B | ||||
| Gross Profit | (58.45 M) | ||||
| EBITDA | (197.76 M) | ||||
| Net Income | (310.38 M) | ||||
| Cash And Equivalents | 63.15 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 166.16 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 0.75 X | ||||
| Book Value Per Share | (5.72) X | ||||
| Cash Flow From Operations | (110.13 M) | ||||
| Earnings Per Share | (57.16) X | ||||
| Market Capitalization | 453.01 M | ||||
| Total Asset | 783.42 M | ||||
| Retained Earnings | (503.19 M) | ||||
| Working Capital | (312.27 M) | ||||
About P3 Health Performance
By evaluating P3 Health's fundamental ratios, stakeholders can gain valuable insights into P3 Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if P3 Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if P3 Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.75) | (0.78) | |
| Return On Capital Employed | (1.01) | (1.06) | |
| Return On Assets | (0.17) | (0.16) | |
| Return On Equity | (2.06) | (2.16) |
Things to note about P3 Health Partners performance evaluation
Checking the ongoing alerts about P3 Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for P3 Health Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners currently holds 166.16 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.5 B. Net Loss for the year was (310.38 M) with loss before overhead, payroll, taxes, and interest of (58.45 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (110.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52. | |
| Roughly 62.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Basel Medical Group Ltd Short Interest Update |
- Analyzing P3 Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether P3 Health's stock is overvalued or undervalued compared to its peers.
- Examining P3 Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating P3 Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of P3 Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of P3 Health's stock. These opinions can provide insight into P3 Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PIII Stock analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |